Search Results

There are 14684 results for: content related to: HCV RNA levels in a multiethnic cohort of injection drug users: Human genetic, viral and demographic associations

  1. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  2. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  3. HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL28B polymorphism

    Journal of Viral Hepatitis

    Volume 20, Issue 3, March 2013, Pages: 193–199, J. Stenkvist, A. Sönnerborg and O. Weiland

    Version of Record online : 20 AUG 2012, DOI: 10.1111/j.1365-2893.2012.01645.x

  4. You have free access to this content
    Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection

    Hepatology

    Volume 57, Issue 6, June 2013, Pages: 2124–2134, Jason Grebely, Jordan J. Feld, Tanya Applegate, Gail V. Matthews, Margaret Hellard, Alana Sherker, Kathy Petoumenos, Geng Zang, Ineke Shaw, Barbara Yeung, Jacob George, Suzy Teutsch, John M. Kaldor, Vera Cherepanov, Julie Bruneau, Naglaa H. Shoukry, Andrew R. Lloyd and Gregory J. Dore

    Version of Record online : 8 MAY 2013, DOI: 10.1002/hep.26263

  5. Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response

    Journal of Viral Hepatitis

    Volume 19, Issue 5, May 2012, Pages: 332–340, P. J. Clark, A. J. Thompson, M. Zhu, D. M. Vock, Q. Zhu, D. Ge, K. Patel, S. A. Harrison, T. J. Urban, S. Naggie, J. Fellay, H. L. Tillmann, K. Shianna, S. Noviello, L. D. Pedicone, R. Esteban, P. Kwo, M. S. Sulkowski, N. Afdhal, J. K. Albrecht, D. B. Goldstein, J. G. McHutchison, A. J. Muir and for the IDEAL investigators

    Version of Record online : 22 FEB 2012, DOI: 10.1111/j.1365-2893.2011.01553.x

  6. You have free access to this content
    Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response

    Hepatology

    Volume 55, Issue 1, January 2012, Pages: 20–29, Yasuhiro Asahina, Kaoru Tsuchiya, Masaru Muraoka, Keisuke Tanaka, Yuichiro Suzuki, Nobuharu Tamaki, Yoshihide Hoshioka, Yutaka Yasui, Tomoji Katoh, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Sayuri Nitta, Naoya Sakamoto and Namiki Izumi

    Version of Record online : 29 NOV 2011, DOI: 10.1002/hep.24623

  7. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  8. You have free access to this content
    Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring

    Hepatology

    Volume 54, Issue 3, 2 September 2011, Pages: 772–780, Alessandra Mangia, Alexander J. Thompson, Rosanna Santoro, Valeria Piazzolla, Massimiliano Copetti, Nicola Minerva, Daniela Petruzzellis, Leonardo Mottola, Donato Bacca and John G. McHutchison

    Version of Record online : 21 JUL 2011, DOI: 10.1002/hep.24458

  9. You have free access to this content
    Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: Impaired viral kinetics and therapeutic response

    Hepatology

    Volume 56, Issue 2, August 2012, Pages: 444–454, Susanna Naggie, Anu Osinusi, Antonios Katsounas, Richard Lempicki, Eva Herrmann, Alexander J. Thompson, Paul J. Clark, Keyur Patel, Andrew J. Muir, John G. McHutchison, Joerg F. Schlaak, Martin Trippler, Bhavana Shivakumar, Henry Masur, Michael A. Polis and Shyam Kottilil

    Version of Record online : 2 JUL 2012, DOI: 10.1002/hep.25647

  10. You have free access to this content
    Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?

    Hepatology

    Volume 56, Issue 1, July 2012, Pages: 373–381, Alexander J. Thompson and John G. McHutchison

    Version of Record online : 3 JUL 2012, DOI: 10.1002/hep.25792

  11. Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 12, November 2014, Pages: 1208–1216, Kentaro Matsuura, Tsunamasa Watanabe, Sayuki Iijima, Shuko Murakami, Kei Fujiwara, Etsuro Orito, Etsuko Iio, Mio Endo, Atsunori Kusakabe, Noboru Shinkai, Tomokatsu Miyaki, Shunsuke Nojiri, Takashi Joh and Yasuhito Tanaka

    Version of Record online : 17 FEB 2014, DOI: 10.1111/hepr.12294

  12. Association of IL28B genotype and viral response of hepatitis C virus genotype 2 to interferon plus ribavirin combination therapy

    Journal of Medical Virology

    Volume 84, Issue 10, October 2012, Pages: 1593–1599, Norio Akuta, Fumitaka Suzuki, Yuya Seko, Yusuke Kawamura, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda and Hiromitsu Kumada

    Version of Record online : 15 AUG 2012, DOI: 10.1002/jmv.23368

  13. You have free access to this content
    Hepatitis C pharmacogenetics: State of the art in 2010

    Hepatology

    Volume 53, Issue 1, January 2011, Pages: 336–345, Nezam H. Afdhal, John G. McHutchison, Stefan Zeuzem, Alessandra Mangia, Jean-Michel Pawlotsky, Jeffrey S. Murray, Kevin V. Shianna, Yasuhito Tanaka, David L. Thomas, David R. Booth, David B. Goldstein and for the Pharmacogenetics and Hepatitis C Meeting Participants

    Version of Record online : 12 JAN 2011, DOI: 10.1002/hep.24052

  14. The Role of Pharmacogenetics in the Treatment of Chronic Hepatitis C Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 2, February 2014, Pages: 185–201, Marina Kawaguchi-Suzuki and Reginald F. Frye

    Version of Record online : 30 SEP 2013, DOI: 10.1002/phar.1349

  15. Early anemia and rapid virological response improve the predictive efficiency of IL28B-genotype for treatment outcome to antiviral combination therapy in patients infected with chronic HCV genotype 1

    Journal of Medical Virology

    Volume 84, Issue 8, August 2012, Pages: 1208–1216, Ahmad Amanzada, Simon Schneider, Federico Moriconi, Alexander Lindhorst, Thomas Suermann, David H. van Thiel, Sabine Mihm and Giuliano Ramadori

    Version of Record online : 18 JUN 2012, DOI: 10.1002/jmv.23323

  16. Association between IL28B polymorphism, TNFα and biomarkers of insulin resistance in chronic hepatitis C-related insulin resistance

    Journal of Viral Hepatitis

    Volume 22, Issue 11, November 2015, Pages: 890–896, M. Lemoine, S. Chevaliez, J. P. Bastard, L. Fartoux, O. Chazouillères, J. Capeau, J. M. Pawlotsky and L. Serfaty

    Version of Record online : 26 MAR 2015, DOI: 10.1111/jvh.12408

  17. You have free access to this content
    Role of IL28B for chronic hepatitis C treatment toward personalized medicine

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 2, February 2014, Pages: 241–249, Kentaro Matsuura, Tsunamasa Watanabe and Yasuhito Tanaka

    Version of Record online : 27 JAN 2014, DOI: 10.1111/jgh.12475

  18. You have free access to this content
    Host genomics and HCV treatment response

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 2, February 2012, Pages: 212–222, Paul J Clark and Alexander J Thompson

    Version of Record online : 20 JAN 2012, DOI: 10.1111/j.1440-1746.2011.06918.x

  19. Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 1, January 2014, Pages: 102–109, Ming-Yao Chen, Chen-Hua Liu, Ting-Chih Chen, Tung-Hung Su, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao and Chun-Jen Liu

    Version of Record online : 19 DEC 2013, DOI: 10.1111/jgh.12329

  20. Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 3, March 2013, Pages: 443–449, Norio Itokawa, Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Satomi Hashimoto, Takeshi Fukuda, Yoko Matsushita, Hideko Kidokoro, Tamaki Kobayashi, Yoshiyuki Narahara, Katsuhisa Nakatsuka, Hidenori Kanazawa, Katsuhiko Iwakiri and Choitsu Sakamoto

    Version of Record online : 26 FEB 2013, DOI: 10.1111/jgh.12039